The Public Health Company commercialized a modeling approach into subscription software that combines genomic variant analysis, epidemiologic investigations and conventional public-health data to help organizations detect, contain and manage disease outbreaks. Its platform automates analytic tools so decision-makers do not need in-house mathematicians, data scientists or infectious-disease doctors to interpret results. The company targets both government partners and private-sector enterprises with global operations—risk and continuity teams for warehouses, factories, insurers and hedge funds are cited as potential customers. Founder Charity Dean developed the underlying model during her public-health work and participated in state-level pandemic modeling efforts. The startup was formed last August and has grown to about 20 employees. Financially, it has secured $8 million in seed funding from institutional investors. The team positions disease risk management as a core continuity and insurance consideration analogous to cybersecurity.

Total raised

$8M

Funding rounds

1

Latest round

Seed

Latest activity

May 2021